The analysis of previous clinical trial data found that for patients with cardiovascular disease who were overweight or obese, those taking semaglutide had fewer hospital admissions and spent less time in hospital
However, this can cause stomach upset, lack of appetite due to sluggish digestion, and irregular digestive patterns
GIP medications, on the other hand, focus on stimulating insulin release in response to meals and have a more pronounced effect on lipid metabolism
Specifically, it stimulates insulin release, slows gastric emptying, and reduces glucagon secretion
Further, the digested peptides were desalted using the sample preparation protocol from Evosep Biosystems
Always seek the guidance of your physician or other qualified health provider with any questions you may have regarding your health or a medical condition